DrugPatentWatch Database Preview

Drugs in Development Information for abraxane

« Back to Dashboard

Summary for abraxane

US Patents	647
International Patents	10,666
US Patent Applications	9,057
WIPO Patent Applications	0
Japanese Patent Applications	215
Clinical Trial Progress	Phase 3 (2018-03-12)
Vendors	57

US Patents for abraxane

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
abraxane		Compositions and methods for glucose transport inhibition	Ohio University (Athens, OH)
abraxane		Heterocyclic compounds useful in the treatment of disease	Epigen Biosciences, Inc. (San Diego, CA)
abraxane		Pyrazol-3-ones that activate pro-apoptotic BAX	Dana-Farber Cancer Institute, Inc. (Boston, MA)
abraxane		Compounds and their methods of use	Agios Pharmaceuticals, Inc. (Cambridge, MA)
abraxane		1H-pyrrolo[2,3-B] pyridine derivatives and their use as kinase inhibitors	Vernalis (R&D) Limited (Winnersh, GB)
abraxane		Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof	Dana-Farber Cancer Institute, Inc. (Boston, MA) Beth Israel Deaconess Medical Center, Inc. (Boston, MA)
abraxane		Selective proton coupled folate transporter and folate receptor, and GARFTase inhibitor compounds and methods of using the same	Duquesne University of the Holy Spirit (Pittsburgh, PA)

International Patents for abraxane

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
abraxane	Canada	2794266	2030-03-24
abraxane	China	103037690	2030-03-24
abraxane	China	105837411	2030-03-24
abraxane	European Patent Office	2549863	2030-03-24
abraxane	World Intellectual Property Organization (WIPO)	2011119866	2030-03-24
abraxane	Australia	2014232383	2033-03-15
abraxane	Brazil	112015023267	2033-03-15